The survival period of breast cancer patients is not only related to the clinical stage, but also needs to be analyzed together with pathological grading, immunohistochemistry type and other factors, and the earlier the patient receives active treatment, the longer the survival period is.
Stage 3 breast cancer belongs to the middle and late stage of breast cancer, and it is also the stage of local progression, the disease progresses faster, and the tumor is prone to local recurrence and distant metastasis, but if early treatment can be taken, the survival rate of the patients is relatively high, but there is no clear statistical data on the specific survival rate.
Survival rate of breast cancer patients is not only related to clinical stage, but also needs to be analyzed in combination with pathological grading, immunohistochemistry type, patient’s age and other factors. It is recommended that patients receive regular treatment as early as possible to improve prognosis and prolong survival.
Once diagnosed with stage 3 breast cancer, patients need to take treatment as early as possible, most of them can be treated with surgery, chemotherapy, radiotherapy, endocrine therapy, immunotherapy, targeted drug therapy and so on, and they need to follow the doctor’s instructions to go to the hospital for regular review after treatment.